FDA notifications. FDA approves new Kaletra formulation.
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D061466:Lopinavir; D011744:Pyrimidinones / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir